In our study, YTHDF1 deficiency significantly promoted tumor MHC-I expression and subsequently led to an enhanced T-cell recognition as evidenced by the increased infiltration of CD4+ and CD8+ T cells, and expanded TCR clone type in the TME. The gene discussed is YTHDF1; the disease is neoplasm.